Skip to main content
SpringerLink
Log in

Prophylaxis for Venous Thromboembolism in Hip Fracture Surgery

Total Costs and Cost Effectiveness in The Netherlands

  • Original Research Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Fracture of the hip is one of most significant risk factors for development of deep vein thrombosis (DVT) and its complications. A number of pharmacological prophylactic methods are currently available which can reduce the incidence of postoperative thromboembolism in patients undergoing surgery for fracture of the hip. A retrospective analysis of controlled clinical studies was performed to examine in this patient group the total cost of prevention and treatment, and the cost effectiveness in terms of lives saved, of 5 prophylactic regimens — oral anticoagulants, dextran, low dose heparin, low molecular weight (LMW)-heparin and danaparoid sodium — compared with clinical diagnosis and conventional treatment of DVT only.

Our results show that the total cost, including the savings in treatment of the complications of DVT, of each prophylactic regimen is less than the total cost of no prophylaxis. Thus, prophylaxis may not only save lives but may also lead to lower costs of care (including prophylaxis costs). The total cost of the new antithrombotic danaparoid sodium is less than that of the other forms of prophylaxis considered and danaparoid sodium appears to be the most cost-effective modality.

We conclude that general use of danaparoid sodium in surgery for hip fracture is the most efficient approach to decreasing the incidence of postoperative morbidity and mortality and reducing healthcare expenses for the complications of DVT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bergqvist D. Post operative thromboembolism: frequency, etiology, prophylaxis, Springer-Verlag, Berlin, 1983

  • Bergqvist D. Oral anticoagulants for prophylaxis against postoperative thromboembolism. Acta Chirurgica Scandinavica 543 (Suppl.): 43–47, 1988

    PubMed  CAS  Google Scholar 

  • Bergqvist D, Jendteg S, Lindgren B, Mätzsch T, Persson U. The economics of general thromboembolic prophylaxis. World Journal of Surgery 12: 349–355, 1988

    Article  PubMed  CAS  Google Scholar 

  • Bergqvist D, Kettunen K, Freddin H, Fauno P, Suomalainen O, et al. Thromboprophylaxis in hip fracture patients — a prospective randomized comparative study between Org 10172 and dextran 70. Surgery 109: 617–622, 1991

    PubMed  CAS  Google Scholar 

  • Bergqvist D. Orgaran in hip fracture surgery. Haemostasis 22: 104–108, 1992

    PubMed  CAS  Google Scholar 

  • Cummings SR. Epidemiology of hip fractures. In Christiansen et al. (Eds) Osteoporosis 1987, pp. 40–40, Osteopress Ltd, Copenhagen, 1987

    Google Scholar 

  • Fareed J. Venous thromboprophylaxis in the 1990’s: a perspective. Seminars in Thrombosis and Hemostasis 17: 317–321, 1991

    Article  PubMed  CAS  Google Scholar 

  • Fenech A, Winter JH, Bennet B, Smith FW, Douglas AS. Preoperative frequency of deep venous thrombosis in patients with fractured neck of the femur. Lancet 1: 1212, 1982

    Google Scholar 

  • Freedman MD. Low molecular weight heparins: an emerging new class of glycosaminoglycan antithrombotics. Journal of Clinical Pharmacology 31: 298–306, 1991

    PubMed  CAS  Google Scholar 

  • Gerhart T, Yett HS, Robertson L, Lee MA, Smith M, et al. Low molecular weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fractures of the hip. Journal Bone and Joint Surgery 73A: 494–502, 1991

    Google Scholar 

  • Haake DA, Berkman SA. Venous thromboembolic disease after hip surgery. Clinical Orthopaedics and Related Research 242: 212–231, 1988

    Google Scholar 

  • Hauch O, Khattar SC, Jorgensen LN. Cost-benefit analysis of prophylaxis against deep thrombosis in surgery. Seminars in Thrombosis and Hemostasis 17 (Suppl. 3): 280–283, 1991

    Article  PubMed  Google Scholar 

  • Hirsh J. Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures. Acta Chirurgica Scandinavica 556 (Suppl.): 30–35, 1990

    PubMed  CAS  Google Scholar 

  • Hirsh J. Low molecular weight heparin. Thrombosis and Haemostasis 70: 204–207, 1993

    PubMed  CAS  Google Scholar 

  • Hull RD, Hirsh J, Sackett DL, Stoddart GL. Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Canadian Medical Association Journal 127: 990–995, 1982

    PubMed  CAS  Google Scholar 

  • Jarnlo G-B, Jakobsson B, Ceder L, Thorngren K-G. Hip fracture incidence in Lund, Sweden 1966–1986. Acta Orthopaedica Scandinavica 60: 278–282, 1989

    Article  PubMed  CAS  Google Scholar 

  • Jorgensen PS, Torholm C, Knudsen JB, Boeng L, Josefson L, et al. Thromboprophylactic effect of a low molecular weight heparin (Fragmin) in acute hip fracture surgery: a placebo controlled study. Thrombosis and Haemostasis 62: 525, 1989

    Google Scholar 

  • Lindblad B. Prophylaxis of post-operative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. Acta Chirurgica Scandinavica 543 (Suppl.): 31–42, 1988

    PubMed  CAS  Google Scholar 

  • Monreal M, Lafoz E, Navarro A, Granera X, Caja C, et al. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin 3 times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture. Journal of Trauma 29: 873–875, 1989

    Article  PubMed  CAS  Google Scholar 

  • Ofosu FA. Low-molecular-weight heparins. Drug News and Perspectives 2: 141–145, 1989

    Google Scholar 

  • Oster G, Tuden RL, Colditz GA. A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery. Journal of the American Medical Association 257: 203–208, 1987

    Article  PubMed  CAS  Google Scholar 

  • Paiement GD, Wessinger SJ, Harris WH. Cost-effectiveness of prophylaxis in total hip replacement. American Journal of Surgery 161: 519–524, 1991

    Article  PubMed  CAS  Google Scholar 

  • Røise O, Nurmohamed M, Reijnders P, Touzard R, Stiekema J, et al. A multicentre, randomised, assessor-blind pilot study comparing the efficacy in the prophylaxis of DVT and the safety of Orgaran (Org 10172), Fragmin, Clexane/Lovenox in patients undergoing surgery for a fractured hip. Thrombosis and Haemostasis 69: 620, 1993

    Google Scholar 

  • Royal College of Physicians. Fractured neck of femur: prevention and management, The Royal College of Physicians of London, London, 1989

  • Salzman EW. Low-molecular-weight heparin and other new anti-thrombotic drugs. New England Journal of Medicine 326: 1017–1019, 1992

    Article  PubMed  CAS  Google Scholar 

  • Salzman EW, Davies GC. Prophylaxis of venous thromboembolism: analysis of cost-effectiveness. Annals of Surgery 191: 207–218, 1980

    Article  PubMed  CAS  Google Scholar 

  • Salzman EW, Hirsh J. Prevention of venous thromboembolism. In Colman et al. (Eds) Hemostasis and thrombosis — basic principles and clinical practice, 2nd ed., pp. 1252–1265, J.B. Lippincott, Philadelphia, 1987

    Google Scholar 

  • SIG/Informatiecentrum voor de Gezondheidszorg. Jaarboek Zieken-huizen 1990, SIG Utrecht, 1991

  • Toulemonde F. Post-operative pulmonary embolism and meta-analysis. Thrombosis Research 67: 275–276, 1992

    Article  PubMed  CAS  Google Scholar 

  • Toulemonde F, Doutremepuich C. Is pulmonary embolism a suitable criterion of the efficacy of prophylactic treatment in surgery? Seminars in Thrombosis and Hemostasis 17: 326–331, 1991

    Article  PubMed  CAS  Google Scholar 

  • Van Beek EJR, Büller HR, Van Royen EA, Van Everdingen JJE, Ten Cate JW. Het diagnostisch beleid bij vermoeden van longembolie: resultaten van een enquete onder Nederlandse internisten en long-artsen. Nederlands Tijdschrift voor Geneeskunde 136: 319–322, 1992

    PubMed  Google Scholar 

  • Van Vroonhoven ThJMV. Consensus preventie van diep veneuze thrombose. Nederlands Tijdschrift voor Geneeskunde 133: 2233–2237, 1989

    PubMed  Google Scholar 

  • Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine 296(13): 716–721, 1977

    Article  PubMed  CAS  Google Scholar 

  • Wille-Jorgensen P. Prophylaxis of postoperative thromboembolism. Danish Medical Bulletin 38: 203–228, 1991

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Organon International BV, Oss, The Netherlands

    Wim E. M. Mol

  2. Department of Pharmacy, Reinier de Graaf Hospital, R de Graafweg 7, 2625, AD Delft, The Netherlands

    Toine C. G. Egberts

Authors
  1. Wim E. M. Mol
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toine C. G. Egberts
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mol, W.E.M., Egberts, T.C.G. Prophylaxis for Venous Thromboembolism in Hip Fracture Surgery. Pharmacoeconomics 5, 48–55 (1994). https://doi.org/10.2165/00019053-199405010-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199405010-00007

Keywords

Search

Navigation